0001214659-20-007257.txt : 20200817 0001214659-20-007257.hdr.sgml : 20200817 20200817162451 ACCESSION NUMBER: 0001214659-20-007257 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200813 FILED AS OF DATE: 20200817 DATE AS OF CHANGE: 20200817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniels Mark CENTRAL INDEX KEY: 0001753840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 201110430 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-49453.xml PRIMARY DOCUMENT X0306 4 2020-08-13 0001581280 Twist Bioscience Corp TWST 0001753840 Daniels Mark C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false See Remarks Common Stock 2020-08-13 4 M false 14502 5.95 A 68220 D Common Stock 2020-08-13 4 S false 7500 65.00 D 60720 D Common Stock 2020-08-13 4 S false 7002 64.03 D 53718 D Common Stock 2020-08-14 4 M false 9006 5.95 A 62724 D Common Stock 2020-08-14 4 S false 7500 66.00 D 55224 D Common Stock 2020-08-14 4 S false 1506 67.00 D 53718 D Employee Stock Option (right to buy) 5.95 2020-08-13 4 M false 14502 0 D 2026-08-29 Common Stock 14502 40878 D Employee Stock Option (right to buy) 5.95 2020-08-14 4 M false 9006 0 D 2026-08-29 Common Stock 9006 31872 D The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer, and Secretary /s/ William Solis, as Attorney-in-Fact for Mark Daniels 2020-08-17